Clinical Trials on Skin-to-skin in United Kingdom
Total 22911 results
-
UCB CelltechCompletedMild to Moderate PsoriasisUnited Kingdom
-
Arxx TherapeuticsRecruitingHealthy Volunteers | Mild to Moderate PsoriasisUnited Kingdom
-
Rachel BakerCompleted
-
Royal Victoria InfirmaryBritish Skin FoundationCompletedModerate to Severe Atopic EczemaUnited Kingdom
-
Kettering Health NetworkOhio UniversityCompletedKangaroo Care | Prenatal Education | Video | Skin-to-skinUnited States
-
ESM Technologies, LLCActive, not recruitingSkin Elasticity | Skin Hydration | Hair Health | Skin Barrier to Water Loss | Fingernail HealthUnited States
-
Mead Johnson NutritionWithdrawnCow's Milk Allergy | Intolerance to Extensively Hydrolyzed Formulas | Intolerance to Breast MilkUnited Kingdom
-
University of ArizonaNational Cancer Institute (NCI)RecruitingOther Skin Changes Due to Chronic Exposure to Nonionizing RadiationUnited States
-
Novartis PharmaceuticalsCompletedModerate to Severe Nail PsoriasisGermany, Belgium, Spain, United States, Australia, United Kingdom, Denmark, Czechia, Greece
-
Wake Forest University Health SciencesCompleted
-
Wake Forest University Health SciencesCompletedSkin to Skin Contact in Cesarean DeliveriesUnited States
-
DeRoyal Industries, Inc.Lincoln Memorial UniversityCompletedSkin Sensitisation | Skin Reaction to Mechanical, Thermal and Radiation StimuliUnited States
-
Kristian Reich, MDLEO PharmaCompletedMild to Moderate PsoriasisUnited Kingdom, Germany, France, Spain, Netherlands, Sweden, Italy, Denmark
-
Tufts Medical CenterCentocor, Inc.CompletedModerate to Severe Palmar Plantar PsoriasisUnited States
-
University of California, San FranciscoCompletedModerate to Severe PsoriasisUnited States
-
BioPharmX, Inc.CompletedModerate to Severe Papulopustular RosaceaUnited States
-
Merz North America, Inc.Ulthera, IncCompletedMild to Moderate Skin Laxity Under the Chin | Mild to Moderate Skin Laxity on NeckUnited States
-
UCB Biopharma SRLActive, not recruitingModerate to Severe Plaque PsoriasisUnited States, Canada, Germany, Poland
-
Novartis PharmaceuticalsCompletedModerate to Severe Plaque PsoriasisUnited States
-
Biocon Biologics UK LtdActive, not recruitingModerate to Severe Chronic Plaque PsoriasisUnited States
-
Bristol-Myers SquibbTerminatedPsoriasis, Moderate to SevereUnited States
-
Dong-A ST Co., Ltd.Meiji Seika Pharma Co., Ltd.CompletedModerate to Severe Chronic Plaque PsoriasisUnited States
-
AbbVie (prior sponsor, Abbott)CompletedModerate to Severe Plaque PsoriasisUnited States, Austria, Belgium, Canada, Denmark, Finland, France, Germany, Greece, Italy, Spain, Sweden, Switzerland, United Kingdom
-
Momentum DataPfizerCompletedAllergic Rhinitis | Deep Vein Thrombosis | Venous Thromboembolism | Atopic Dermatitis | Pulmonary Embolism | Food Allergy | Allergy to House Dust Mite | Allergy to Animal Dander | Cows Milk AllergyUnited Kingdom
-
Actavis Inc.CompletedModerate to Severe Papulopustular RosaceaUnited States
-
Novartis PharmaceuticalsCompletedModerate to Severe Palmoplantar PsoriasisBelgium, United States, Hungary, Russian Federation, Turkey, Australia, Israel, Netherlands, Portugal, Spain, United Kingdom, Norway, Slovakia, Canada, Finland
-
DeviceFarm, Inc.Symbio, LLC; Center for Dermatology Clinical Research, Inc.CompletedOnychomycosis Due to Trichophyton Rubrum | Onychomycosis Due to Trichophyton MentagrophytesUnited States
-
Sun Pharmaceutical Industries LimitedRecruitingModerate to Severe Plaque PsoriasisUnited States, El Salvador
-
University of NottinghamCompletedEvidence of Adaptation to Dietary Exposure to FructansUnited Kingdom
-
TakedaNimbus Lakshmi, Inc.; Innovaderm Research Inc.CompletedModerate to Severe Plaque PsoriasisUnited States, Canada
-
Solta MedicalCompleted
-
Novartis PharmaceuticalsCompletedModerate to Severe Plaque-type PsoriasisUnited States, Czech Republic, Austria, Germany, India, Japan, Bulgaria, Singapore, Switzerland, United Kingdom, Italy, France, Poland, Slovakia, Canada, Vietnam
-
Fresenius Kabi SwissBioSim GmbHMerck KGaA, Darmstadt, GermanyCompletedPsoriasis | Moderate to Severe Plaque Psoriasis | Plaque Type PsoriasisUnited States, Canada, Czechia, Hungary, Russian Federation, Bulgaria, Mexico, United Kingdom, Poland, Germany, Estonia, France
-
Jiangsu HengRui Medicine Co., Ltd.CompletedModerate-to-severe Chronic Plaque PsoriasisUnited States, Australia, China
-
AbGenomics B.V Taiwan BranchCompletedModerate to Severe Chronic Plaque PsoriasisUnited States
-
Barco NVTerminatedSkin Cancer | Dermatology/Skin - OtherUnited Kingdom
-
Bausch Health Americas, Inc.TerminatedModerate to Severe Plaque PsoriasisUnited States, Austria, France, Poland, Australia, Czechia, Canada, Hungary, Portugal, Spain, Netherlands
-
Novartis PharmaceuticalsCompletedModerate to Severe Plaque-type PsoriasisGermany, United States, Belgium, Colombia, Spain, Estonia, Hungary, Japan, Lithuania, Taiwan, Australia, Korea, Republic of, Canada, Singapore, Italy, Israel, Sweden, Guatemala, United Kingdom, Argentina, France, Poland, Latvia, Iceland, Finla... and more
-
AbGenomics B.V Taiwan BranchCompletedModerate to Severe Chronic Plaque PsoriasisUnited States
-
Novartis PharmaceuticalsCompletedModerate to Severe Chronic Plaque-Type PsoriasisUnited States, Germany, Japan, Bulgaria, Czechia, Singapore, Switzerland, United Kingdom, Italy, France, Vietnam, Poland, Slovakia, Austria, Canada
-
UCB Biopharma SRLCompletedModerate to Severe Chronic Plaque Psoriasis | Chronic Plaque PsoriasisUnited States, Australia, Belgium, Canada, France, Germany, Netherlands, Poland, Spain, Turkey, United Kingdom
-
AbbVie (prior sponsor, Abbott)Paragon BiomedicalCompletedModerate to Severe Plaque PsoriasisUnited States
-
Skin Analytics LimitedInnovate UKCompleted
-
Janssen Biotech, Inc.CompletedModerate to Severe Plaque PsoriasisUnited States
-
Idera Pharmaceuticals, Inc.CompletedModerate to Severe Plaque Psoriasis | Actively Extending Plaque PsoriasisUnited States
-
Genzyme, a Sanofi CompanyCompletedModerate to Severe Chronic Plaque PsoriasisUnited States
-
Novartis PharmaceuticalsCompletedModerate to Severe Plaque-type PsoriasisGermany, United States, Estonia, France, Canada
-
Keele UniversityCompletedPatient Acceptability to Being Invited to Take Part in Research of Relevance to ThemUnited Kingdom
-
University of ManchesterCompleted
-
Sun Pharmaceutical Industries LimitedRecruitingModerate-to-severe Chronic Plaque PsoriasisUnited States, Hungary, India, Poland, Slovakia, Spain